ARCHIVED - Canadian National Report on Immunization, 2006
Volume: 32S3 - November 2006
ANNEX 2 : List of Abbreviations and Acronyms
| ACCA | Advisory Committee on Causality Assessment |
| AEFI | Adverse event following immunization |
| AFP | Acute flaccid paralysis |
| AIVP | Automated Identification of Vaccine Products |
| CAEFISS | Canadian Adverse Event Following Immunization Surveillance System |
| CCDR | Canada Communicable Disease Report |
| CDC | US Centers for Disease Control and Prevention |
| CIHR | Canadian Institutes of Health Research |
| CIRN | Canadian Immunization Registry Network |
| CIC | Canadian Immunization Committee |
| CNCI | Canadian Nursing Coalition on Immunization |
| CPS | Canadian Paediatric Society |
| CPSP | Canadian Paediatric Surveillance Program |
| CRI | Congenital rubella infection |
| CRS | Congenital rubella syndrome |
| DTaP | Diphtheria, tetanus, acellular pertussis infant vaccine |
| EHSSS | Enhanced Hepatitis Strain Surveillance System |
| F/P/T | Federal/Provincial/Territorial |
| FNIHB | First Nations and Inuit Health Branch |
| GBS | Guillain-Barré syndrome |
| HB | Hepatitis B vaccine |
| HBV | Hepatitis B virus |
| HHE | Hypotonic-hyporesponsive episode |
| Hib | Haemophilus influenzae type b |
| HMDB | Hospital Morbidity Database |
| HPV | Human papillomavirus |
| ICS | International Circumpolar Surveillance |
| ILI | Influenza-like illness |
| IMD | Invasive meningococcal disease |
| IMPACT | Immunization Monitoring Program, ACTive |
| Inf | Influenza vaccine |
| IPD | Invasive pneumococcal disease |
| IPV | Inactivated poliovirus vaccine |
| IRID | Immunization and Respiratory Infections Division |
| KAB | Knowledge, attitudes and beliefs |
| LTCF | Long-term care facility |
| Men-C | Meningococcal conjugate vaccine |
| Men-P | Meningococcal polysaccharide vaccine |
| MMR | Measles/mumps/rubella vaccine |
| NACI | National Advisory Committee on Immunization |
| NDRS | Notifiable Diseases Reporting System |
| NICS | National Immunization Coverage Survey |
| NIS | National Immunization Strategy |
| OPV | Oral poliovirus vaccine |
| ORS | Oculo-respiratory syndrome |
| PAHO | Pan-American Health Organization |
| PHAC | Public Health Agency of Canada |
| Pneu-C-7 | 7-valent pneumococcal conjugate vaccine |
| Pneu-P-23 | 23-valent pneumococcal polysaccharide vaccine |
| RVDSS | Respiratory Virus Detection Surveillance System |
| SARS | Severe Acute Respiratory Syndrome |
| Td | Tetanus, diphtheria adult vaccine |
| Tdap | Tetanus, diphtheria, acellular pertussis adult vaccine |
| UNICEF | United National Children's Fund |
| VAAES | Vaccine Associated Adverse Events Surveillance System |
| Var | Varicella vaccine |
| VIDS | Vaccine Identification Database System |
| VPRIS | Vaccine-Preventable and Respiratory Infections Surveillance working group |
| VSWG | Vaccine Supply Working Group |
| WHO | World Health Organization |
| WPV | Wild polio virus |
Page details
- Date modified: